Objectives The Regional CardioCerebroVascular Center (RCCVC) project was initiated to improve clinical outcomes for patients with acute myocardial infarction or stroke in non-capital areas of Korea. The purpose of this study was to evaluate the outcomes and issues identified by the Busan RCCVC project in the treatment of ST-segment elevation myocardial infarction (STEMI).
Methods Among the patients who were registered in the Korean Registry of Acute Myocardial Infarction for the RCCVC project between 2007 and 2019, those who underwent percutaneous coronary intervention (PCI) for STEMI at the Busan RCCVC were selected, and their medical data were compared with a historical cohort.
Results In total, 1161 patients were selected for the analysis. Ten years after the implementation of the Busan RCCVC project, the median door-to-balloon time was reduced from 86 (interquartile range [IQR], 64-116) to 54 (IQR, 44-61) minutes, and the median symptom-to-balloon time was reduced from 256 (IQR, 180-407) to 189 (IQR, 118-305) minutes (p<0.001). Inversely, the false-positive PCI team activation rate increased from 0.6% to 21.4% (p<0.001). However, the 1-year cardiovascular death and major adverse cardiac event rates did not change. Even after 10 years, approximately 75% of the patients had a symptom-to-balloon time over 120 minutes, and approximately 50% of the patients underwent inter-hospital transfer for primary PCI.
Conclusions A decade after the implementation of the Busan RCCVC project, although time parameters for early reperfusion therapy for STEMI improved, at the cost of an increased false-positive PCI team activation rate, survival outcomes were unchanged.
Summary
Korean summary
이번 연구에서는 부산권역심뇌혈관질환센터사업 시작 후 10여년간의 ST분절상습심근경색 환자 치료성적의 변화를 살펴보았다.
사업 시작 후 관상동맥중재시술팀의 위양성소집률이 크게 증가한 대신 ST분절상승심근경색 환자의 조기재관류 치료의 시간지표는
의미 있게 개선되었다. 그러나 생존지표는 사업 시작 전과 비교해 차이가 없었는데 중재시술이 불가능한 병원을 경우하는 사례가
많아 골든타임 이내에 조기 재관류치료를 받은 환자의 비율이 전체 환자의 1/4에 불과한 것이 그 원인으로 보인다.
Citations
Citations to this article as recorded by
Relevance Index Regional Variation by Each Disease and Its Essential Medical Field: A Retrospective Data Analysis From 2016-2020 in Korea Young-Eun Kim, Jeehee Pyo, Haneul Lee, HyeRan Jeong, Young-Kwon Park, Jeong-Wook Seo, Minsu Ock, Seok-Jun Yoon Journal of Korean Medical Science.2023;[Epub] CrossRef
Objectives This study aims to investigate trends of cardiovascular disease (CVD) risk factor profiles over 17 years in percutaneous coronary intervention (PCI) patients at the Mayo Clinic. Methods: We performed a time-trend analysis within the Mayo Clinic PCI Registry from 1994 to 2010. Results were the incidence and prevalence of CVD risk factors as estimate by the Framingham risk score. Results: Between 1994 and 2010, 25 519 patients underwent a PCI. During the time assessed, the mean age at PCI became older, but the gender distribution did not change. A significant trend towards higher body mass index and more prevalent hypercholesterolemia, hypertension, and diabetes was found over time. The prevalence of current smokers remained unchanged. The prevalence of ever-smokers decreased among males, but increased among females. However, overall CVD risk according to the Framingham risk score (FRS) and 10-year CVD risk significantly decreased. The use of most of medications elevated from 1994 to 2010, except for β-blockers and angiotensin converting enzyme inhibitors decreased after 2007 and 2006 in both baseline and discharge, respectively. Conclusions: Most of the major risk factors improved and the FRS and 10-year CVD risk declined in this population of PCI patients. However, obesity, history of hypercholesterolemia, hypertension, diabetes, and medication use increased substantially. Improvements to blood pressure and lipid profile management because of medication use may have influenced the positive trends.
Summary
Citations
Citations to this article as recorded by
Can conventional cardiovascular risk prediction models be improved by nuclear magnetic resonance (NMR) metabolomic signatures? Remya Sudevan European Journal of Preventive Cardiology.2023; 30(3): 241. CrossRef
Worse outcomes of ACS patients without versus with traditional cardiovascular risk factors Arthur Shiyovich, Tal Ovdat, Robert Klempfner, Roy Beigel, Majdi Halabi, Avinoam Shiran, Keren Skalsky, Avital Porter, Katia Orvin, Ran Kornowski, Alon Eisen Journal of Cardiology.2022; 79(4): 515. CrossRef
Heterogeneity of Treatment Effects for Intensive Blood Pressure Therapy by Individual Components of FRS: An Unsupervised Data-Driven Subgroup Analysis in SPRINT and ACCORD Yaqian Wu, Jianling Bai, Mingzhi Zhang, Fang Shao, Honggang Yi, Dongfang You, Yang Zhao Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef
Radial artery access is under‐utilized in women undergoing PCI despite potential benefits: Mayo Clinic PCI Registry Rebecca C. Chester, Syeda A. Mina, Bradley Lewis, Nan Zhang, Richard Butterfield, Eric H. Yang Catheterization and Cardiovascular Interventions.2020; 95(4): 675. CrossRef
Temporal trends of patients with acute coronary syndrome and multi-vessel coronary artery disease - from the ACSIS registry Arthur Shiyovich, Nir Shlomo, Tal Cohen, Zaza Iakobishvili, Ran Kornowski, Alon Eisen International Journal of Cardiology.2020; 304: 8. CrossRef
Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II Jocelyn J. Drinkwater, Timothy M. E. Davis, Valentina Hellbusch, Angus W. Turner, David G. Bruce, Wendy A. Davis Cardiovascular Diabetology.2020;[Epub] CrossRef
Trends of Cardiovascular Risk Factors in Patients With Acute Myocardial Infarction: Soroka Acute Myocardial Infarction II (SAMI II) Project Ygal Plakht, Abeer Abu Eid, Harel Gilutz, Arthur Shiyovich Angiology.2019; 70(6): 530. CrossRef
Sedentary lifestyle and Framingham risk scores: a population-based study in Riyadh city, Saudi Arabia AlJohara M. AlQuaiz, Amna Rehana Siddiqui, Ambreen Kazi, Mohammad Ali Batais, Ali M. Al-Hazmi BMC Cardiovascular Disorders.2019;[Epub] CrossRef
Use of Global Risk Score for Cardiovascular Evaluation of Rural Workers in Southern Brazil Marta Regina Cezar-Vaz, Clarice Alves Bonow, Marlise Capa Verde Almeida de Mello, Daiani Modernel Xavier, Jordana Cezar Vaz, Maria Denise Schimith The Scientific World Journal.2018; 2018: 1. CrossRef
12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study SeyedHossein Rabani, Mahsa Sardarinia, Samaneh Akbarpour, Fereidoun Azizi, Davood Khalili, Farzad Hadaegh, Katriina Aalto-Setala PLOS ONE.2018; 13(5): e0195543. CrossRef
Cardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: Results from the first Jordanian percutaneous coronary intervention study Ayman J. Hammoudeh, Imad A. Alhaddad, Yousef Khader, Ramzi Tabbalat, Eyas Al-Mousa, Akram Saleh, Mohamad Jarrah, Assem Nammas, Mahmoud Izraiq Journal of the Saudi Heart Association.2017; 29(3): 195. CrossRef
Changing Trends of Atherosclerotic Risk Factors Among Patients With Acute Myocardial Infarction and Acute Ischemic Stroke Shikhar Agarwal, Karan Sud, Badal Thakkar, Venu Menon, Wael A. Jaber, Samir R. Kapadia The American Journal of Cardiology.2017; 119(10): 1532. CrossRef
Cardiovascular manifestations of renovascular hypertension in diabetic mice Sonu Kashyap, Sean Engel, Mazen Osman, Yousif Al-Saiegh, Asarn Wongjarupong, Joseph P. Grande PeerJ.2016; 4: e1736. CrossRef
Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents Anna Franzone, Thomas Pilgrim, Dik Heg, Marco Roffi, David Tüller, André Vuilliomenet, Olivier Muller, Stéphane Cook, Daniel Weilenmann, Christoph Kaiser, Peiman Jamshidi, Lorenz Räber, Stefan Stortecky, Peter Wenaweser, Peter Jüni, Stephan Windecker Circulation: Cardiovascular Interventions.2015;[Epub] CrossRef
OBJECTIVES To compare the performance of three comorbidity measurements (Charlson comorbidity index, Elixhauser's comorbidity and comorbidity selection) with the effect of different comorbidity lookback periods when predicting in-hospital mortality for patients who underwent percutaneous coronary intervention. METHODS: This was a retrospective study on patients aged 40 years and older who underwent percutaneous coronary intervention. To distinguish comorbidity from complications, the records of diagnosis were drawn from the National Health Insurance Database excluding diagnosis that admitted to the hospital. C-statistic values were used as measures for in comparing the predictability of comorbidity measures with lookback period, and a bootstrapping procedure with 1,000 replications was done to determine approximate 95% confidence interval. RESULTS: Of the 61,815 patients included in this study, the mean age was 63.3 years (standard deviation: +/-10.2) and 64.8% of the population was male. Among them, 1,598 (2.6%) had died in hospital. While the predictive ability of the Elixhauser s comorbidity and comorbidity selection was better than that of the Charlson comorbidity index, there was no significant difference among the three comorbidity measurements. Although the prevalence of comorbidity increased in 3 years of lookback periods, there was no significant improvement compared to 1 year of a lookback period. CONCLUSIONS: In a health outcome study for patients who underwent percutaneous coronary intervention using National Health Insurance Database, the Charlson comorbidity index was easy to apply without significant difference in predictability compared to the other methods. The one year of observation period was adequate to adjust the comorbidity. Further work to select adequate comorbidity measurements and lookback periods on other diseases and procedures are needed.
Summary
Citations
Citations to this article as recorded by
Adjusting for Confounders in Outcome Studies Using the Korea National Health Insurance Claim Database: A Review of Methods and Applications Seung Jin Han, Kyoung Hoon Kim Journal of Preventive Medicine and Public Health.2024; 57(1): 1. CrossRef
High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study Sungho Bea, In‐Sun Oh, Ju Hwan Kim, Dong Hyun Sinn, Yoosoo Chang, Seungho Ryu, Ju‐Young Shin Journal of the American Heart Association.2023;[Epub] CrossRef
Impact of comorbidity assessment methods to predict non-cancer mortality risk in cancer patients: a retrospective observational study using the National Health Insurance Service claims-based data in Korea Sanghee Lee, Yoon Jung Chang, Hyunsoon Cho BMC Medical Research Methodology.2021;[Epub] CrossRef
Evaluating the impact of covariate lookback times on performance of patient-level prediction models Jill Hardin, Jenna M. Reps BMC Medical Research Methodology.2021;[Epub] CrossRef
Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012) Abbey Diaz, Peter D. Baade, Patricia C. Valery, Lisa J. Whop, Suzanne P. Moore, Joan Cunningham, Gail Garvey, Julia M. L. Brotherton, Dianne L. O’Connell, Karen Canfell, Diana Sarfati, David Roder, Elizabeth Buckley, John R. Condon, Stéphanie Filleur PLOS ONE.2018; 13(5): e0196764. CrossRef
Comorbidity Adjustment in Health Insurance Claim Database Kyoung Hoon Kim Health Policy and Management.2016; 26(1): 71. CrossRef
The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access Lorenzo Azzalini, Kunle Tosin, Malorie Chabot-Blanchet, Robert Avram, Hung Q. Ly, Benoit Gaudet, Richard Gallo, Serge Doucet, Jean-François Tanguay, Réda Ibrahim, Jean C. Grégoire, Jacques Crépeau, Raoul Bonan, Pierre de Guise, Mohamed Nosair, Jean-Franço JACC: Cardiovascular Interventions.2015; 8(14): 1854. CrossRef
A Convergence Study in the Severity-adjusted Mortality Ratio on inpatients with multiple chronic conditions Young-Suk Seo, Sung-Hong Kang Journal of Digital Convergence.2015; 13(12): 245. CrossRef
Development and validation of comorbidity index in South Korea S.-R. Kil, S.-I. Lee, Y.-H. Khang, M.-S. Lee, H.-J. Kim, S.-O. Kim, M.-W. Jo International Journal for Quality in Health Care.2012; 24(4): 391. CrossRef
Development of Mortality Model of Severity-Adjustment Method of AMI Patients Ji-Hye Lim, Mun-Hee Nam Journal of the Korea Academia-Industrial cooperation Society.2012; 13(6): 2672. CrossRef
Use of hospitalisation history (lookback) to determine prevalence of chronic diseases: impact on modelling of risk factors for haemorrhage in pregnancy Jian Sheng Chen, Christine L Roberts, Judy M Simpson, Jane B Ford BMC Medical Research Methodology.2011;[Epub] CrossRef
The Impact of Medicaid Expansion to include population with low income on the preventable hospitalizations Hyun-Chul Shin, Se-Ra Kim Korean Journal of Health Policy and Administration.2010; 20(1): 87. CrossRef
Comparative Study on Three Algorithms of the ICD-10 Charlson Comorbidity Index with Myocardial Infarction Patients Kyoung Hoon Kim Journal of Preventive Medicine and Public Health.2010; 43(1): 42. CrossRef